IRIS
LUPO, Luigi Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.609
AS - Asia 2.337
EU - Europa 1.959
SA - Sud America 527
AF - Africa 86
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.527
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.526
SG - Singapore 1.090
CN - Cina 616
DE - Germania 468
BR - Brasile 457
HK - Hong Kong 316
SE - Svezia 315
RU - Federazione Russa 291
IT - Italia 192
UA - Ucraina 191
FI - Finlandia 156
GB - Regno Unito 140
VN - Vietnam 122
FR - Francia 72
CI - Costa d'Avorio 50
IN - India 49
CA - Canada 41
AR - Argentina 34
MX - Messico 28
NL - Olanda 28
BE - Belgio 24
BD - Bangladesh 22
AT - Austria 20
ID - Indonesia 17
IR - Iran 15
IE - Irlanda 14
PL - Polonia 13
JP - Giappone 12
TR - Turchia 12
ZA - Sudafrica 12
ES - Italia 10
IQ - Iraq 10
AE - Emirati Arabi Uniti 8
EC - Ecuador 8
CO - Colombia 7
EG - Egitto 7
SA - Arabia Saudita 7
KE - Kenya 6
AU - Australia 5
CL - Cile 5
PY - Paraguay 5
UZ - Uzbekistan 5
VE - Venezuela 5
AZ - Azerbaigian 4
CR - Costa Rica 4
JO - Giordania 4
MK - Macedonia 4
OM - Oman 4
PE - Perù 4
RO - Romania 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AL - Albania 3
IL - Israele 3
KZ - Kazakistan 3
MY - Malesia 3
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
JM - Giamaica 2
KI - Kiribati 2
LT - Lituania 2
MA - Marocco 2
PH - Filippine 2
PK - Pakistan 2
PT - Portogallo 2
TM - Turkmenistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BN - Brunei Darussalam 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KR - Corea 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
NG - Nigeria 1
NP - Nepal 1
RS - Serbia 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UY - Uruguay 1
Totale 10.527
Salva come PNG Salva come JPEG
Città #
Fairfield 586
Singapore 559
Ashburn 558
Chandler 505
Jacksonville 424
Woodbridge 388
Hong Kong 316
Cambridge 261
Nyköping 258
Houston 248
Seattle 232
Wilmington 223
Ann Arbor 221
Beijing 193
Dallas 133
Munich 127
Lawrence 110
Roxbury 109
Nanjing 98
Los Angeles 78
Des Moines 76
New York 72
Boardman 60
Ho Chi Minh City 52
Abidjan 50
Helsinki 50
Princeton 48
Shenyang 45
Inglewood 42
Bari 41
Brooklyn 39
São Paulo 35
Jiaxing 32
Buffalo 28
San Diego 28
Hanoi 25
Brussels 24
Nanchang 24
Santa Clara 24
Dearborn 23
Eboli 22
London 22
Marseille 21
San Francisco 21
Toronto 20
Tianjin 19
Rio de Janeiro 17
Nuremberg 16
Paris 16
Changsha 15
Hebei 15
Belo Horizonte 14
Redwood City 14
Dublin 13
Augusta 12
Chicago 12
Guangzhou 12
Montreal 12
Moscow 12
Tokyo 12
Warsaw 12
Ardabil 11
Amsterdam 10
Chennai 10
Denver 10
Salvador 10
Vienna 10
Curitiba 9
Falls Church 9
San Mateo 9
Atlanta 8
Boston 8
Columbus 8
Jakarta 8
Leawood 8
Mexico City 8
Pune 8
The Dalles 8
Washington 8
Zhengzhou 8
Brasília 7
Grafing 7
Hangzhou 7
Jinan 7
Johannesburg 7
Mumbai 7
Orem 7
Porto Alegre 7
Rome 7
Shanghai 7
Auburn Hills 6
Goiânia 6
Manchester 6
Nairobi 6
Norwalk 6
Phoenix 6
Poplar 6
Stockholm 6
Council Bluffs 5
Dhaka 5
Totale 7.070
Salva come PNG Salva come JPEG
Nome #
Down-Staging in Liver Transplatation for HCC. Audit of an Experience 208
NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC 179
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients 173
Targeting angiogenesis in biliary tract cancers: An open option 153
Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts 152
Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma 145
D-MELD, a strong and accurate tool to guide Donor -2- Recipient Matching 144
Protective colostomy closure: the hazards of a "minor" operation 142
Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma 138
TROMBOPOIETINA E PIASTRINOPENIA NEI PAZIENTI SOTTOPOSTI A TRAPIANTO DI FEGATO (OLT):RISULTATI PRELIMINARI SU 21 PAZIENTI 132
Reliability of clinical judgement in evaluation of the nutritional status of surgical patients 128
Randomized clinical trial of radiofrequency-assisted versus clamp-crushing liver resection 128
Improved accuracy of computed tomography in local staging of rectal cancer using water enema 126
Elective versus emergency full thickness rectal prolapse treatment using a perineal approach - a video vignette 125
Is pyloric function preserved in pylorus-preserving pancreaticoduodenectomy? 122
Radiofrequency ablation of HCC on liver cirrhosis. Evaluation of effect by spiral-CT and pathology on native livers of trasplanted patients 121
Accuratezza diagnostica dello staging dell’HCC nei pazienti con cirrosi: la lezione dei trapianti di fegato 121
Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial 120
A national mandatory-split liver policy: A report from the Italian experience 119
Laparoscopic management of neuroendocrine tumors: State-of-the-art 112
Lipoprotein(a), lipids and proinflammatory cytokines in patients undergoing major abdominal surgery 111
Prediction of mortality by logistic regression analysis in patients with postoperative enterocutaneous fistulae. 110
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C. 110
A Bayesan methodology to improve of early graft loss after liver transplantation derived from the Liver Match study 110
Tempo di ischemia fredda e produzione di trombopoietina(TPO) nel trapianto ortotopico di fegato: risultati preliminari su 21 casi 109
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients 106
Behind D-MELD :the role of primary indication (HCV or HBV) as significant Covariate in the Outcome Prediction after Liver Transplant 104
Safe use of Grafts from HBcAb Positive Donors in Liver Transplantation -Analysis of Matching and Outcome 103
Platelets and hepatocellular cancer: Bridging the bench to the clinics 102
MELD predictive value of alterations of brain perfusion during liver transplantation 101
Postoperative changes in serum interleukin-2 concentrations 101
D-MELD, a powerful Instrument to Optimize Donor -2-Recipient Match.Differences betweenUS and Italy 100
Anatomical hepatic resection using radiofrequency thermoablation in the treatment of primary or secondary liver tumors 99
Prognostic Value of Neutrophil/Lymphocyte Ratio in Liver Transplantation for HCC 98
Resection vs radiofrequency ablation for HCC from 3 to 5 cm: A single centre experience on 101 child- pugh class A-B naive patients 98
Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? 98
Facing HCV recurrence after liver transplantation: antiviral therapy response and clinical out come 98
State of lucid delirium after orthotopic liver transplantation. Clinical case 97
Down-staging in Liver Transplantation for HCC 96
Plasma concentrations but not serum concentrations of brain-derived neurotrophic factor are related to pro-inflammatory cytokines in patients undergoing major abdominal surgery 94
Irisin improves the secretory defects of pancreatic islets from type 2 diabetic subjects 94
ACUTE PANCREATITIS AFTER ORTOTOPIC LIVER TRANSPLANTATION 89
RECTAL-CARCINOMA - CT STAGING WITH WATER AS CONTRAST-MEDIUM 89
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial 88
Azione della pentossifillina sulla evoluzione in guarigione delle ferite sperimentali nel coniglio 87
Increased in vitro and in vivo generation of procoagulant activity (tissue factor) by mononuclear phagocytes after Intralipid infusion in rabbits 86
null 86
RUOLO DEL TIPO DI PERFUSIONE NEL PRELIEVO DI FEGATO A SCOPO DI TRAPIANTO 85
Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC 85
TROMBOPOIETINA (TPO) E TROMBOCITOPENIA NEI PAZIENTI SOTTOPOSTI A TRAPIANTO DI FEGATO: STUDIO PRELIMINARE SU 9 CASI 85
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis 85
THE UN-SUSTAINABLE MATCH IN HCV LIVER TRANSPLANT PATIENTS 84
STATE OF LUCID DELIRIUM AFTER ORTHOTOPIC LIVER TRANSPLANTATION 83
LIVER RELATED EVENTS (LRE) IN PATIENTS WITH ESTABLISHED HCV RECURRENT DISEASE AFTER LIVER TRANSPLANTATION COULD BE PREDICTED BY LIVER STIFFNESS MEASUREMENT (LSM). 83
Liver Match, a prospective observational cohort study on liver transplantation in Italy: Study design and current practice of donor-recipient matching 83
Basiliximab vs Steroids in liver transplantation immunosuppression. A prospective randomized clinical trial. 82
Tempo di ischemia fredda e produzione di trombopoietina(TPO)nel trapianto ortotopico di fegato (OLT): studio preliminare sui primi 9 casi. 82
Hepatocellular carcinoma progression is accelerated by cancer associated fibroblasts stimulated by tumor production of lysophosphatidic acid 82
Radiofrequency ablation of HCC on liver cirrhosis. Evaluation of effect by spiral-CT and pathology on native livers of trasplanted patients 82
null 81
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients 81
[Blood flow assessment with Doppler color ultrasonography in primary and secondary tumors of the liver]. FT Valutazioni flussimetriche con eco color Doppler nei tumori epatici primitivi e secondari. 80
Solutions for organ perfusion and storage: haemorheologic aspects 80
Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosi in 961 patients 80
Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin-332/α3 integrin axis recovery of focal adhesion kinase ubiquitination 80
TROMBOPOIETINA E PIASTRINOPENIA NEI PZ. SOTTOPOSTI A TRAPIANTO DI FEGATO(OLT): RISULTATI PRELIMINARI SU 21 PZ 78
Evaluation of RFA of HCC in patients underwent LTx: Spiral-CT and Pathology on native livers 78
Manuale di Metodologia della Ricerca ClinicA 76
OPTIMIZATION OF DONOR-RECIPIENT MATCH AND IDENTIFICATION OF THE FUTILE MATCH CUTOFF. A NATIONAL ITALIAN STUDY ON LIVER TRANSPLANTATION. 76
null 76
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 76
Reduction of postoperative immunosuppression with ranitidine in patients with cancer of the stomach or large bowel 75
Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect of surgical drainage 75
Role of perioperative parenteral nutrition in patients submitted to curative surgery for gastric carcinoma. 75
EFFECT OF PERIOPERATIVE WHOLE BLOOD VS LEUCOCYTE-DEPLETED BLOOD TRANSFUSION ON SURVIVAL AFTER CURATIVE SURGERY FOR COLORECTAL 74
The tumor microenvironment regulates HCC growth rate 74
Terapia fibrinolitica nel trattamento delle ulcere venose post-flebitiche 73
Reliable Steroid-Free Immunosuppression in Liver Transplantation 73
Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression 72
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment 72
Fattori prognostici nel trattamento sclerosante delle varici esofagee sanguinanti: Studio preliminare 70
Reliability and accuracy of the hepatic perfusion index as a diagnostic test for liver metastases. 70
Hemorheological and microcirculation in healthy and diseased liver after liver transplantation: a review. 70
null 70
STUDIO DELL'MCP-1 (MONOCYTE CHEMOATTRACTANT PROTEIN) NEL TRAPIANTO DI FEGATO 69
Limited prognostic value of staging systems for hepatocellular carcinoma on cirrhosis 69
Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma 69
Reliability of clinical judgement in evaluation of the nutritional-status of surgial patients. 68
[Gene expression of the MAGE-1, -3, and -6 antigens in hepatic carcinoma]. FT Espressione genica degli antigeni MAGE-1, -3, -6 nell'epatocarcinoma. 67
PI3K class 1B controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma 67
Laminin-5 stimulates hepatocellular carcinoma growth through a different function of alpha 6 beta 4 and alpha 3 beta 1 integrins 66
Worse Graft Survival in HCV-Infected Transplanted Females Receiving a Male Donor Graft. The Liver Match Study 65
Liver transplantation with hepatitis B core antibodypositive graft under hepatitis b Immunoglobulin and lamivudine prophilaxis 63
null 63
Resection vs radiofrequency ablation for HCC from 3 to 5cm: A single centre experience on 101 child-pugh class A-B naive patients 62
Valutazione prognostica delle fistole enterocutanee post operatorie: confronto fra due sistemi prognostici 61
HSP70 and VEGF blood levels in patients with hepatocellular carcinoma (HCC) 59
Hepatitis B-core antibody positive donors in Liver Trasplantation and their impact on graft survival:Evidence from the Liver Match cohort study 59
Post-surgical trauma acute inflammation. A molecular analysis 57
LONG-TERM OUTCOME OF LIVER RESECTION FOR HCC IN CIRRHOTIC PATIENTS 56
Totale 9.358
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.507
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.507
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021577 0 0 0 0 0 45 88 52 116 117 100 59
2021/2022840 19 127 10 46 21 50 39 49 39 38 138 264
2022/20231.350 182 120 84 118 162 196 18 154 245 7 33 31
2023/2024408 33 81 24 36 38 94 21 23 0 6 11 41
2024/20251.977 22 22 159 44 58 189 189 219 102 85 267 621
2025/20262.131 565 211 287 404 481 183 0 0 0 0 0 0
Totale 10.644